Mrs Sharon Lynn Rogers, APN | |
1200 Mclain St, Newport, AR 72112-3534 | |
(870) 523-9852 | |
(870) 523-3583 |
Full Name | Mrs Sharon Lynn Rogers |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Adult Health |
Location | 1200 Mclain St, Newport, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518123868 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SA2200X | Clinical Nurse Specialist - Adult Health | S02231 CNS (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Sharon Lynn Rogers, APN 7648 Victory Blvd, Newport, AR 72112-8912 Ph: (870) 512-7833 | Mrs Sharon Lynn Rogers, APN 1200 Mclain St, Newport, AR 72112-3534 Ph: (870) 523-9852 |
News Archive
Research from Northumbria University, Newcastle, has shown the important role specific types of exercise can play in the management of bone loss, fatigue and muscle dysfunction for those with Crohn's disease.
Whether or not you can taste a bitter compound called 6-n-propylthiouracil (or PROP) may help Professor Beverly Tepper identify your risk for becoming obese and/or developing cardiovascular disease.
The federal government is investing tens of billions of dollars in health information technology, but the medical groups that stand to benefit from the money are less enthusiastic than their government benefactors, arguing that the push is "too much, too soon," Politico reports.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
› Verified 5 days ago